|
Gene Therapy
Citations 1-10 of 385 total displayed.
|
Most recent content
(1 May 2008):
|
Development of gene therapy for blood disorders
- Arthur W. Nienhuis
Blood 2008; 111: 4431-4444.
[Abstract]
[Full text]
[PDF]
|
Past content
(since Aug 1998):
|
Neutrophil-selective CD18 silencing using RNA interference in vivo
- Xavier Cullere, Michael Lauterbach, Naotake Tsuboi, and Tanya N. Mayadas
Blood 2008; 111: 3591-3598.
[Abstract]
[Full text]
[PDF]
An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation
- Byoung Y. Ryu, Marguerite V. Evans-Galea, John T. Gray, David M. Bodine, Derek A. Persons, and Arthur W. Nienhuis
Blood 2008; 111: 1866-1875.
[Abstract]
[Full text]
[PDF]
Locus control region elements HS1 and HS4 enhance the therapeutic efficacy of globin gene transfer in β-thalassemic mice
- Leszek Lisowski and Michel Sadelain
Blood 2007; 110: 4175-4178.
[Abstract]
[Full text]
[PDF]
Deletions within the HSV-tk transgene in long-lasting circulating gene-modified T cells infused with a hematopoietic graft
- Marina Deschamps, Patricia Mercier-Lethondal, Jean Marie Certoux, Carole Henry, Bruno Lioure, Céline Pagneux, Jean Yves Cahn, Eric Deconinck, Eric Robinet, Pierre Tiberghien, and Christophe Ferrand
Blood 2007; 110: 3842-3852.
[Abstract]
[Full text]
[PDF]
Selecting highly affine and well-expressed TCRs for gene therapy of melanoma
- Annelies Jorritsma, Raquel Gomez-Eerland, Maarten Dokter, Willeke van de Kasteele, Yvonne M. Zoet, Ilias I. N. Doxiadis, Nathalie Rufer, Pedro Romero, Richard A. Morgan, Ton N. M. Schumacher, and John B. A. G. Haanen
Blood 2007; 110: 3564-3572.
[Abstract]
[Full text]
[PDF]
Co-expression of cytokine and suicide genes to enhance the activity and safety of tumor-specific cytotoxic T lymphocytes
- Concetta Quintarelli, Juan F. Vera, Barbara Savoldo, Greta M. P. Giordano Attianese, Martin Pule, Aaron E. Foster, Helen E. Heslop, Cliona M. Rooney, Malcolm K. Brenner, and Gianpietro Dotti
Blood 2007; 110: 2793-2802.
[Abstract]
[Full text]
[PDF]
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer
- Catherine M. Bollard, Stephen Gottschalk, Ann M. Leen, Heidi Weiss, Karin C. Straathof, George Carrum, Mariam Khalil, Meng-fen Wu, M. Helen Huls, Chung-Che Chang, M. Victoria Gresik, Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, and Helen E. Heslop
Blood 2007; 110: 2838-2845.
[Abstract]
[Full text]
[PDF]
Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens
- Lucienne M. Ide, Bagirath Gangadharan, Kuang-Yueh Chiang, Christopher B. Doering, and H. Trent Spencer
Blood 2007; 110: 2855-2863.
[Abstract]
[Full text]
[PDF]
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver
- Federico Mingozzi, Nicole C. Hasbrouck, Etiena Basner-Tschakarjan, Shyrie A. Edmonson, Daniel J. Hui, Denise E. Sabatino, Shangzhen Zhou, J. Fraser Wright, Haiyan Jiang, Glenn F. Pierce, Valder R. Arruda, and Katherine A. High
Blood 2007; 110: 2334-2341.
[Abstract]
[Full text]
[PDF]
|
|
